Genesco SVP granted 376 restricted shares

Gray Andrew reported acquisition or exercise transactions in this Form 4 filing.

Accepted by SEC EDGAR 04/07/2026 - 04:02 PM EDT

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Gray Andrew reported acquisition or exercise transactions in this Form 4 filing.

GENESCO INC Senior VP Andrew Gray received a grant of company stock. He was awarded 376 shares of common stock as restricted stock under the Third Amended and Restated 2020 Equity Incentive Plan, increasing his direct holdings to 87,371 shares following the grant. This is a compensation-related equity award, not an open-market trade.

Insider Trade Summary

Grant/Award: 376 shares

Grant/Award 1 txn

Insider Gray Andrew

Role Senior VP

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	376	$0.00	$0.00

Holdings After Transaction: Common Stock — 87,371 shares (Direct)

Footnotes (1)

F1. Grant of restricted stock under the Third Amended and Restated 2020 Equity Incentive Plan.

Key Figures

Restricted stock grant: 376 shares Post-transaction holdings: 87,371 shares Transaction code: Code A

3 metrics

Restricted stock grant 376 shares Common Stock awarded to Senior VP on April 2, 2026

Post-transaction holdings 87,371 shares Andrew Gray direct common stock position after grant

Transaction code Code A Grant, award, or other acquisition of non-derivative common stock

Key Terms

restricted stock, Third Amended and Restated 2020 Equity Incentive Plan, Form 4

3 terms

restricted stock financial

"Grant of restricted stock under the Third Amended and Restated 2020 Equity Incentive Plan."

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Third Amended and Restated 2020 Equity Incentive Plan financial

"Grant of restricted stock under the Third Amended and Restated 2020 Equity Incentive Plan."

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did GENESCO INC (GCO) report for Andrew Gray?

GENESCO INC reported that Senior VP Andrew Gray received 376 shares of common stock as a grant of restricted stock. The award was made under the company’s Third Amended and Restated 2020 Equity Incentive Plan as part of his equity-based compensation.

Was Andrew Gray’s Form 4 transaction in GCO a purchase or a grant?

The Form 4 shows a grant, not a market purchase. Andrew Gray acquired 376 shares of GENESCO INC common stock at zero price as restricted stock awarded under the 2020 Equity Incentive Plan, classed as a grant, award, or other acquisition.

How many GENESCO INC (GCO) shares does Andrew Gray hold after this grant?

After receiving the 376-share restricted stock grant, Andrew Gray directly holds 87,371 shares of GENESCO INC common stock. This post-transaction balance reflects his position following the compensation award reported in the Form 4 insider filing.

What plan governed Andrew Gray’s restricted stock grant at GENESCO INC (GCO)?

The grant was made under GENESCO INC’s Third Amended and Restated 2020 Equity Incentive Plan. This plan authorizes equity-based compensation, including restricted stock awards, to executives and other eligible participants as part of long-term incentive programs.

Did Andrew Gray sell any GENESCO INC (GCO) shares in this Form 4 filing?

No sales were reported in this Form 4. The filing shows only an acquisition of 376 restricted shares as a grant, with no dispositions, exercises, or tax-withholding transactions disclosed for the reported date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gray Andrew

(Last)

(First)

(Middle)

C/O GENESCO INC.

535 MARRIOTT DRIVE

(Street)

NASHVILLE

TENNESSEE

37214

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
GENESCO INC [ GCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Senior VP

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	04/02/2026		A		376⁽¹⁾	A	$0.00	87,371	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Grant of restricted stock under the Third Amended and Restated 2020 Equity Incentive Plan.

	Scott E. Becker, Attorney-in-Fact	04/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR